Infectivity-Enhanced Adenoviruses for Improved Replicative Oncolysis
Abstract
We have been developing conditionally replicative adenoviral agents (CRADs) for prostate cancer gene therapy. We have sought to improve these agents by increasing their infectivity for tumor targets and by enhancing the specificity of their replication exclusively within tumor targets.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 2002
- Accession Number
- ADA405416
Entities
People
- David T. Curiel
Organizations
- University of Alabama